| Acquirer | Target | Price |
|---|---|---|
| Nichi-Iko Pharmaceutical Co. Lt.d | Sagent Pharmaceuticals Inc. | $736 million |
| Thoma Bravo LLC | Imprivata, Inc. | $544 million |
| Evolent Health, Inc. | Valence Health, Inc. | $145 million |
| PGIM Real Estate | Solana Willistown & Solana Roseland | $98.25 million |
| LTC Properties, Inc. | Village at Athens | $14.3 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
